D-Mannose (C₆H₁₂O₆, monosaccharide) · supplement
Evidence tier: insufficient
Prevents urinary tract infections by competitively blocking E. coli adhesion to urinary tract cells, directly cleared in the urine for targeted action
D mannose is a simple sugar that is absorbed and then largely excreted unchanged into the urine. Once there it is thought to act as a decoy: uropathogenic E. coli grip bladder cells using a protein called FimH that binds mannose, so free mannose floating in the urine occupies those grippers and the bacteria are voided rather than anchoring. It has no antibacterial action, so it cannot drive resistance. This mechanism is well characterised in the laboratory and is the entire basis of the product's reputation. MERIT is the reminder that a good mechanism is not a clinical effect.
Insufficient, and this is a recent reversal. The single largest and only properly blinded trial of D mannose is MERIT (Hayward G et al, JAMA Internal Medicine 2024, PMID 38587819): 598 women with recurrent UTI across 99 UK primary care practices, randomised double blind against placebo for six months. It was NEGATIVE. A medically attended UTI occurred in 51.0 percent of the D mannose group and 55.7 percent of the placebo group, with no difference in symptom severity, time to next consultation, or antibiotic use. The authors' conclusion is explicit: D mannose should not be recommended to prevent future episodes of medically attended UTI in women with recurrent UTI in primary care. The 2025 systematic review and meta analysis (PMID 41004704, 6 RCTs) reaches the same place: pooled RR 0.57, 95 percent CI 0.29 to 1.15, NOT statistically significant, with severe heterogeneity (I squared 87 percent), and its stated conclusion is that D mannose did not reduce the incidence of recurrent UTI compared with control or antibiotics. The positive literature everyone quotes rests on small, single centre, OPEN LABEL trials, above all Kranjcec 2014, which was not blinded and compared against no treatment at all. When the trial was finally done properly, the effect vanished. The mechanism is real and elegant. The clinical benefit is not established.
MERIT used 2 g daily as a powder for six months, and found it no better than placebo. No dose has been shown to work.
For prevention: take 500mg to 2g daily. For acute UTI treatment: take 2g three times daily for 3 days. Take with a full glass of water. Unlike antibiotics, does not affect the gut microbiome.
Onset: ~3 days
Exceptionally well tolerated, one of the safest supplements available. High doses (>2g per dose) may cause loose stools or bloating. Diabetics should monitor blood sugar at high doses. Does not treat complicated UTI, pyelonephritis, or systemic infection, medical care required for these.
Pregnancy: caution
Breastfeeding: caution
Not a traditional botanical remedy, D-mannose is a naturally occurring sugar found in fruits such as cranberries and apples. Its therapeutic use emerged from modern nutritional research into UTI prevention. There is no traditional herbal medicine history for D-mannose as an isolated supplement.
Active compounds: D mannose
Remedies using D-Mannose · Browse by body system · Check it against what you take
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.